ClinicalTrials.gg
Not yet recruitingNCT07949734Updated Nov 19, 2026

Spinal Cord Blood Flow Measurement

An interventional study of Ventilatory manipulation in Spinal Cord Injuries (SCI), sponsored by University of Calgary. Not yet recruiting at 1 site in Canada. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by University of Calgary · Not applicable, Interventional, and Other

How we know

Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 204 studies in Spinal Cord Injuries with a site in Canada — 67 open to participants now, 74 under way, 4 of them phase 3. Spinal Cord Injuries · Canada.

Planned enrollment
113th of 179
16 · median 24
Started
2027
with 6 others
No phase
127 of 204
52 open now
Primary completion
2030-01
later than 65 of 73 live
Registered
204th of 204
by date
Lead sponsor
7 of 204
University of Calgary

Among the 204 studies in Spinal Cord Injuries with a site in Canada, this one is the 113th largest by planned enrollment of the 179 interventional ones that give a count, is one of 7 that started in 2027, is one of 127 with no phase, reaches primary completion later than 65 of the 73 other live ones, and was the 204th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

67 of the 204 studies in Spinal Cord Injuries with a site in Canada are open now. Recruiting first, the newest first:

62 more — sign in →

All 67 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 204 studies in Spinal Cord Injuries with a site in Canada, or all of them as a file.
02

Study summary

The purpose of this study is to measure spinal cord blood flow in participants with acute cervical or high-thoracic spinal cord injury. During planned spinal cord decompression surgery after acute spinal cord injury, participants will have a blood flow sensor placed around the area of injury. The participant's breathing rate and depth, which is controlled via a ventilator as part of standard surgical care, will be manipulated to test whether progressively increasing carbon dioxide levels increases spinal cord blood flow. This will provide the first safety data of the effects of altering carbon dioxide intraoperatively for spinal cord injury.

Read the detailed description

This single-centre, prospective, randomised feasibility trial will enroll 16 participants with acute traumatic spinal cord injury (SCI) undergoing surgical decompression at the Foothills Medical Centre.

After SCI, impaired spinal cord perfusion and oxygenation drive secondary injury and worsen recovery. Current care raises systemic blood pressure with vasopressors, which has limited evidence of improving spinal cord oxygenation or neurological outcome. Carbon dioxide (CO₂) is a central nervous system vasodilator, and the investigators have shown preclinical pilot studies that increasing CO₂ increases spinal cord blood flow and oxygenation. This trial is the first test in humans of whether raising arterial CO₂ can increase spinal cord tissue oxygenation during acute SCI.

The investigators will recruit participants with acute SCI undergoing spinal decompression surgery. The investigators will randomise participants to one of two arms. In the intervention arm (n=10), the attending anaesthesiologist will titrate end-tidal CO₂ to 35, 45, 55, and 65 mmHg by adjusting ventilator settings (permissive hypercapnia; no exogenous CO₂ is given), holding each level for approximately five minutes. In the comparison arm (n=6), the investigators will take the same measurements under standard care without manipulating CO₂, to provide reference values. All participants receive full standard surgical and anaesthetic care; the study adds only the intraoperative measurement and, in the intervention arm, the ventilatory manipulation.

Following operative decompression and laminectomy, the investigators will measure spinal cord tissue oxygenation using the Integra LICOX monitoring system, which records tissue partial pressure of oxygen and temperature from a probe placed on the spinal cord tissue. The investigators will record systemic hemodynamics, arterial blood gases, and ventilatory parameters continuously. The investigators will track peri- and post-operative adverse events and clinical endpoints from the medical record, and the investigators will interview participating surgeons, anaesthesiologists, and patients about feasibility and safety.

The specific aims of this trial are to:

  1. Characterise the dose-response relationship between end-tidal CO₂ and spinal cord tissue oxygenation during acute SCI decompression surgery.
  2. Establish the safety and feasibility of intraoperative end-tidal CO₂ titration, considered feasible if spinal cord tissue oxygenation increases by a predefined threshold above baseline.
03

Conditions studied

  • Spinal Cord Injuries (SCI)

Keywords

  • Spinal cord injury
  • Blood flow
  • Oxygenation
  • Nervous system
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-70 presenting with acute SCI between C4-T6
  • Requiring surgical decompression, with or without instrumentation
  • Able to be mechanically ventilated under general anaesthesia for the surgical procedure
  • Able to provide , or with a legally authorized/substitute decision-maker able to provide consent where the participant has impaired capacity in the acute setting, with ongoing consent obtained from the participant following completion of the surgical procedure. Enrollment occurs in the acute setting where capacity may be temporarily impaired

Exclusion criteria

Exclusion Criteria:

  • Known or suspected traumatic brain injury
  • Severe multi-systemic injury or chest trauma
  • Hemodynamically unstable, or otherwise ineligible for surgery
  • Confirmed pregnancy
  • Any other condition that, in the judgment of the attending clinical team or investigators, would make participation unsafe
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
16 participants (estimated)

Study arms

  • Experimental
    Ventilatory manipulation

    The anesthesiologist will intentionally adjust the patient's breathing rate and depth for a brief period to titrate end-tidal CO2 to predetermined levels, which will then be held for 5 min intervals. End-tidal CO₂ will be titrated to 35, 45, 55, and 65 mmHg.

    Other: Ventilatory manipulation

  • No intervention
    Control

    Participants will receive the same standard surgical care the ventilatory manipulation arm, but without intentional adjustment of ventilation to achieve predetermined CO2 levels. Participants in this arm will also have spinal cord oxygenation measured.

Interventions

  • OtherVentilatory manipulation

    Participants will be receiving mechanical ventilation as part of their standard care. The clinical operating team, specifically the attending anesthesiologist, will adjust their level of ventilation (breathing rate, depth) to achieve predetermined levels of end-tidal CO2. Spinal cord oxygenation will be measured in all participants before, during, and after ventilatory manipulation.

06

What researchers measure

Primary outcomes

  1. Spinal cord tissue oxygenation during intraoperative monitoring

    Spinal cord tissue oxygenation, measured as tissue partial pressure of oxygen (PtO₂) using the Integra LICOX monitoring system, recorded continuously during the intraoperative monitoring period in both arms. In the intervention arm, PtO₂ is assessed across stepwise end-tidal CO₂ levels (35, 45, 55, 65 mmHg, held approximately five minutes each) to characterise the dose-response relationship between end-tidal CO₂ and spinal cord tissue oxygenation. In the comparison arm, PtO₂ is recorded under standard care without CO₂ manipulation to provide reference values.

    Time frame: Intraoperative, during the ventilatory titration protocol (approximately 20 to 30 minutes), from pre-titration baseline through each end-tidal CO₂ level (35, 45, 55, 65 mmHg).

Secondary outcomes

  1. Incidence of peri- and post-operative adverse events

    Incidence, type, and severity of peri- and post-operative adverse events (for example, arrhythmias, acid-base disturbance, hemodynamic instability), abstracted from the medical record and coded in alignment with the NINDS Common Data Elements. Events are summarised by arm and by relationship to the study procedures, to assess the safety of intraoperative end-tidal CO₂ titration.

    Time frame: From surgery through acute hospital discharge (up to approximately 30 days).

  2. Systemic blood pressure during intraoperative monitoring

    Systemic blood pressure (mean arterial pressure) recorded continuously during the intraoperative monitoring period in both arms. In the intervention arm, values are assessed across stepwise end-tidal CO₂ levels (35, 45, 55, 65 mmHg) to characterise the hemodynamic response to ventilatory CO₂ manipulation. In the comparison arm, values are recorded under standard care without CO₂ manipulation to provide reference values.

    Time frame: Intraoperative, during the ventilatory titration protocol (approximately 20 to 30 minutes).

  3. Arterial carbon dioxide during intraoperative monitoring

    Arterial blood gas values (PaCO₂, PaO₂, pH) measured from the arterial line and recorded continuously during the intraoperative monitoring period in both arms. In the intervention arm, values are assessed across stepwise end-tidal CO₂ levels (35, 45, 55, 65 mmHg) to confirm the achieved degree of hypercapnia and to monitor acid-base status (protocol conducted only while pH ≥ 7.3). In the comparison arm, values are recorded under standard care without CO₂ manipulation.

    Time frame: Intraoperative, during the monitoring period (approximately 20 to 30 minutes).

  4. Heart rate during intraoperative monitoring

    Heart rate (beats per minute) recorded continuously during the intraoperative monitoring period in both arms. In the intervention arm, values are assessed across stepwise end-tidal CO₂ levels (35, 45, 55, 65 mmHg) to characterise the hemodynamic response to ventilatory CO₂ manipulation. In the comparison arm, values are recorded under standard care without CO₂ manipulation to provide reference values.

    Time frame: Intraoperative, during the ventilatory titration protocol (approximately 20 to 30 minutes).

  5. Arterial oxygen during intraoperative monitoring

    Arterial oxygen values (PaO₂) measured from the arterial line and recorded continuously during the intraoperative monitoring period in both arms. In the intervention arm, values are assessed across stepwise end-tidal CO₂ levels (35, 45, 55, 65 mmHg) to confirm arterial oxygenation is maintained. In the comparison arm, values are recorded under standard care without CO₂ manipulation.

    Time frame: Intraoperative, during the ventilatory titration protocol (approximately 20 to 30 minutes).

  6. Acid-base balance during intraoperative monitoring

    Acid-base balance (pH) measured from the arterial line and recorded continuously during the intraoperative monitoring period in both arms. In the intervention arm, values are assessed across stepwise end-tidal CO₂ levels (35, 45, 55, 65 mmHg) to confirm acid-base balance is maintained. In the comparison arm, values are recorded under standard care without CO₂ manipulation.

    Time frame: Intraoperative, during the ventilatory titration protocol (approximately 20 to 30 minutes).

07

Study locations

1 site
08

References and documents

Publications

  • Agyeman KA, Lee DJ, Russin J, Kreydin EI, Choi W, Abedi A, Lo YT, Cavaleri J, Wu K, Edgerton VR, Liu C, Christopoulos VN. Functional ultrasound imaging of the human spinal cord. Neuron. 2024 May 15;112(10):1710-1722.e3. doi: 10.1016/j.neuron.2024.02.012. Epub 2024 Mar 7. PubMed 38458198 ↗
  • Rashnavadi T, Macnab A, Cheung A, Shadgan A, Kwon BK, Shadgan B. Monitoring spinal cord hemodynamics and tissue oxygenation: a review of the literature with special focus on the near-infrared spectroscopy technique. Spinal Cord. 2019 Aug;57(8):617-625. doi: 10.1038/s41393-019-0304-2. Epub 2019 Jun 4. PubMed 31164734 ↗
  • Tiruvoipati R, Botha JA, Pilcher D, Bailey M. Carbon dioxide clearance in critical care. Anaesth Intensive Care. 2013 Mar;41(2):157-62. doi: 10.1177/0310057X1304100129. PubMed 23530782 ↗
  • Hickling KG, Joyce C. Permissive hypercapnia in ARDS and its effect on tissue oxygenation. Acta Anaesthesiol Scand Suppl. 1995;107:201-8. doi: 10.1111/j.1399-6576.1995.tb04359.x. PubMed 8599278 ↗
  • Ford RW, Malm DN. Therapeutic trial of hypercarbia and hypocarbia in acute experimental spinal cord injury. J Neurosurg. 1984 Nov;61(5):925-30. doi: 10.3171/jns.1984.61.5.0925. PubMed 6436448 ↗
  • Hukuda S, Mochizuki T, Ogata M. Effects of hypertension and hypercarbia on spinal cord tissue oxygen in acute experimental spinal cord injury. Neurosurgery. 1980 Jun;6(6):639-43. doi: 10.1227/00006123-198006000-00004. PubMed 6776423 ↗
  • Yang WC, Wang Q, Chi LT, Wang YZ, Cao HL, Li WZ. Therapeutic hypercapnia reduces blood-brain barrier damage possibly via protein kinase Cepsilon in rats with lateral fluid percussion injury. J Neuroinflammation. 2019 Feb 13;16(1):36. doi: 10.1186/s12974-019-1427-2. PubMed 30760300 ↗
  • Deng RM, Liu YC, Li JQ, Xu JG, Chen G. The role of carbon dioxide in acute brain injury. Med Gas Res. 2020 Apr-Jun;10(2):81-84. doi: 10.4103/2045-9912.285561. PubMed 32541133 ↗
  • Streijger F, So K, Manouchehri N, Gheorghe A, Okon EB, Chan RM, Ng B, Shortt K, Sekhon MS, Griesdale DE, Kwon BK. A Direct Comparison between Norepinephrine and Phenylephrine for Augmenting Spinal Cord Perfusion in a Porcine Model of Spinal Cord Injury. J Neurotrauma. 2018 Jun 15;35(12):1345-1357. doi: 10.1089/neu.2017.5285. Epub 2018 Mar 28. PubMed 29338544 ↗
  • Evaniew N, Davies B, Farahbakhsh F, Fehlings MG, Ganau M, Graves D, Guest JD, Korupolu R, Martin AR, McKenna SL, Tetreault LA, Vedantam A, Brodt ED, Skelly AC, Kwon BK. Interventions to Optimize Spinal Cord Perfusion in Patients With Acute Traumatic Spinal Cord Injury: An Updated Systematic Review. Global Spine J. 2024 Mar;14(3_suppl):58S-79S. doi: 10.1177/21925682231218737. PubMed 38526931 ↗
  • Sajdeya R, Yanez ND, Kampp M, Goodman MD, Zonies D, Togioka B, Nunn A, Winfield RD, Martin ND, Kohli A, Huynh TT, Okonkwo DO, Poblete RA, Gilmore EJ, Chesnut RM, Bunnell AE, Ohnuma T, Hashemaghaie M, Treggiari MM. Early Blood Pressure Targets in Acute Spinal Cord Injury: A Randomized Clinical Trial. JAMA Netw Open. 2025 Sep 2;8(9):e2525364. doi: 10.1001/jamanetworkopen.2025.25364. PubMed 40965887 ↗
  • Williams AM, Manouchehri N, Erskine E, Tauh K, So K, Shortt K, Webster M, Fisk S, Billingsley A, Munro A, Tigchelaar S, Streijger F, Kim KT, Kwon BK, West CR. Cardio-centric hemodynamic management improves spinal cord oxygenation and mitigates hemorrhage in acute spinal cord injury. Nat Commun. 2020 Oct 15;11(1):5209. doi: 10.1038/s41467-020-18905-8. PubMed 33060602 ↗
  • Gee CM, Kwon BK. Significance of spinal cord perfusion pressure following spinal cord injury: A systematic scoping review. J Clin Orthop Trauma. 2022 Sep 11;34:102024. doi: 10.1016/j.jcot.2022.102024. eCollection 2022 Nov. PubMed 36147378 ↗
  • Squair JW, Belanger LM, Tsang A, Ritchie L, Mac-Thiong JM, Parent S, Christie S, Bailey C, Dhall S, Street J, Ailon T, Paquette S, Dea N, Fisher CG, Dvorak MF, West CR, Kwon BK. Spinal cord perfusion pressure predicts neurologic recovery in acute spinal cord injury. Neurology. 2017 Oct 17;89(16):1660-1667. doi: 10.1212/WNL.0000000000004519. Epub 2017 Sep 15. PubMed 28916535 ↗
  • Kwon BK, Tetreault LA, Martin AR, Arnold PM, Marco RAW, Newcombe VFJ, Zipser CM, McKenna SL, Korupolu R, Neal CJ, Saigal R, Glass NE, Douglas S, Ganau M, Rahimi-Movaghar V, Harrop JS, Aarabi B, Wilson JR, Evaniew N, Skelly AC, Fehlings MG. A Clinical Practice Guideline for the Management of Patients With Acute Spinal Cord Injury: Recommendations on Hemodynamic Management. Global Spine J. 2024 Mar;14(3_suppl):187S-211S. doi: 10.1177/21925682231202348. PubMed 38526923 ↗

Individual participant data

Plan to share: Yes — De-identified individual participant data underlying the primary outcome (spinal cord tissue oxygenation, PtO₂) and secondary outcomes (systemic hemodynamics, arterial blood gases, adverse events) will be shared. Only de-identified, processed data will be shared; raw data and qualitative interview transcripts will not be shared. Sharing is subject to approval by the University of Calgary Conjoint Health Research Ethics Board and consistent with participant consent.

Supporting information: Study protocol, Statistical analysis plan, Clinical study report, Analytic code

Time frame: Data and supporting information will be made available after publication of the primary trial results, with no planned end date (data will remain available in the repository indefinitely, subject to repository terms).

Access criteria: De-identified data and supporting documents will be deposited in the Open Data Commons for Spinal Cord Injury (ODC-SCI) repository and shared following FAIR principles. Access will be available to qualified researchers through the repository's standard access process, following University of Calgary ethics and privacy requirements. Custom analysis code will be made available via GitHub. Requests may also be directed to the Principal Investigator (Dr. Aaron Phillips).

Data sharing details ↗ · odc-sci.org

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Jan 2030, 36 months later.

Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 36 months is close to that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 26, 2026
First posted
Nov 19, 2026
StartEst.
Jan 11, 2027
Primary completionEst.
Jan 12, 2030
CompletionEst.
Jan 2032
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07949734
Responsible party
Sponsor
First posted
Nov 19, 2026
Start date
Jan 11, 2027 (estimated)
Primary completion
Jan 12, 2030 (estimated)
Completion
Jan 2032 (estimated)
Last update
Nov 19, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion